Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · IEX Real-Time Price · USD
0.701
+0.009 (1.33%)
At close: Apr 23, 2024, 4:00 PM
0.712
+0.011 (1.54%)
After-hours: Apr 23, 2024, 7:38 PM EDT
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $28.85 million as of April 23, 2024. Its market cap has decreased by -63.89% in one year.
Market Cap
28.85M
Enterprise Value
-63.13M
1-Year Change
-63.89%
Ranking
Category
Stock Price
$0.70
Market Cap Chart
Since the IPO on October 9, 2020, Spruce Biosciences's market cap has decreased from $333.95M to $28.85M, a decrease of -91.36%. That is a compound annual growth rate of -49.93%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 28.80M | 1.05% |
Apr 22, 2024 | 28.50M | -1.04% |
Apr 19, 2024 | 28.80M | - |
Apr 18, 2024 | 28.80M | -1.03% |
Apr 17, 2024 | 29.10M | 1.04% |
Apr 16, 2024 | 28.80M | -1.03% |
Apr 15, 2024 | 29.10M | -3.96% |
Apr 12, 2024 | 30.30M | -3.50% |
Apr 11, 2024 | 31.40M | 1.62% |
Apr 10, 2024 | 30.90M | -2.22% |
Apr 9, 2024 | 31.60M | -2.77% |
Apr 8, 2024 | 32.50M | -6.07% |
Apr 5, 2024 | 34.60M | 0.29% |
Apr 4, 2024 | 34.50M | 1.77% |
Apr 3, 2024 | 33.90M | -2.87% |
Apr 2, 2024 | 34.90M | 3.56% |
Apr 1, 2024 | 33.70M | 4.33% |
Mar 28, 2024 | 32.30M | 5.90% |
Mar 27, 2024 | 30.50M | 5.90% |
Mar 26, 2024 | 28.80M | -3.03% |
Mar 25, 2024 | 29.70M | -1.00% |
Mar 22, 2024 | 30.00M | -3.54% |
Mar 21, 2024 | 31.10M | 1.30% |
Mar 20, 2024 | 30.70M | -0.32% |
Mar 19, 2024 | 30.80M | -1.28% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Surrozen | 29.59M |
Singular Genomics Systems | 29.57M |
NeuroOne Medical Technologies | 29.56M |
NRx Pharmaceuticals | 28.71M |
Acurx Pharmaceuticals | 28.65M |
SeaStar Medical Holding | 28.39M |
Femasys | 28.07M |
Lexaria Bioscience | 28.04M |